Forget about Vivagel, and the FDA, and Viraleze, and India, and the TGA, and condom coatings. Management are not pushing SPL7013 any more, and with the demise of a treatment for conjunctivitis I think the best thing to do is sell it all off to the highest bidder. Whether the company receives an offer that covers it’s outlay over the years is a mute point, but they can concentrate on DEP, which in itself is not a one trick pony.
So, what do I want?
Phase 2 results and proof of concept!
When do I want it?
Now!
- Forums
- ASX - By Stock
- SPL
- Ann: Starpharma receives $7.7M R&D tax incentive refund
Ann: Starpharma receives $7.7M R&D tax incentive refund, page-12
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.31M |
Open | High | Low | Value | Volume |
10.0¢ | 10.0¢ | 9.9¢ | $14.97K | 151.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 372123 | 9.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 5042 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 372123 | 0.099 |
2 | 140000 | 0.098 |
1 | 64565 | 0.097 |
1 | 50000 | 0.095 |
2 | 41737 | 0.094 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 5042 | 1 |
0.105 | 99818 | 1 |
0.110 | 226808 | 10 |
0.115 | 122327 | 4 |
0.120 | 139405 | 10 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |